Respir Crit Care Med.,
171: 1209–23 (2005).
6. Kipnis E., et al., Med Mal Infect., 36:
78–91 (2006).
7. Laarman AJ., et al., J Immunol., 188:
386–93 (2012).
8. King JD., et al.
Respir Crit Care Med.,
171, 1209–23 (2005).
6. Kipnis E., et al., Med Mal Infect., 36, 78–91
(2006).
7. Laarman AJ., et al., J Immunol., 188, 386–93
(2012).
8. King JD., et al.
U., Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I., et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S., et al., J. Neuroimmunol., 72, 155
(1997).
6. Birkedal-Hansen, H., et
Ovchinnikov, Y. A., et al., The synthesis and some
properties of beauvericin. Tetrahedron Lett.,
12(2), 159-162 (1971).
3. Braden, B., et al., Crystal structure of a
beauvericin-barium picrate complex.
U., Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I. et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S. et al., J. Neuroimmunol., 72, 155
(1997).
6. Birkedal-Hansen, H. et
, Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I., et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S., et al., J. Neuroimmunol., 72, 155
(1997).
6. Birkedal-Hansen, H.
U., Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I., et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S., et al., J. Neuroimmunol., 72, 155
(1997).
6. Birkedal-Hansen, H., et
, U., Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I., et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S., et al., J. Neuroimmunol., 72, 155
(1997).
6. Birkedal-Hansen, H., et
, Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I., et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S., et al., J. Neuroimmunol., 72, 155
(1997).
6. Birkedal-Hansen, H.
U., Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I., et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S., et al., J. Neuroimmunol., 72, 155
(1997).
6. Birkedal-Hansen, H., et
, Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I., et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S., et al., J. Neuroimmunol., 72, 155
(1997).
6. Birkedal-Hansen, H.
, U., Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I., et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S., et al., J. Neuroimmunol., 72, 155
(1997).
6. Birkedal-Hansen, H., et
, Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I., et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S., et al., J. Neuroimmunol., 72, 155
(1997).
6. Birkedal-Hansen, H.
, U., Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I., et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S., et al., J. Neuroimmunol., 72, 155
(1997).
6. Birkedal-Hansen, H., et
1997).
9. Levitan, D., et al., Proc. Natl. Acad. Sci. USA, 93,
14940-14944 (1996).
10. Baumeister, R., et al., Genes Function, 1, 149-159
(1997).
11. Wong, P., et al., Nature, 387, 288-292 (1997
, Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I., et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S., et al., J. Neuroimmunol., 72, 155
(1997).
6. Birkedal-Hansen, H.
U., Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I., et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S., et al., J. Neuroimmunol., 72, 155
(1997).
6. Birkedal-Hansen, H., et
, U., Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I., et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S., et al., J. Neuroimmunol., 72, 155
(1997).
6. Birkedal-Hansen, H., et
References
1. Damen, J. E., et al., Proc. Natl. Acad. Sci. USA, 93,
1689-1693 (1996).
2. Kavanaugh, W. M., et al., Curr. Biol., 6, 438-445
(1996).
3. Lioubin, M. N., et al., Genes Dev., 10
of the invoice or packing slip.
5. de Boer TP., et al., Br J Pharmacol., 159, 1532-
41 (2010).
6. Yoshida C. and Takeichi M., Cell, 28, 217-24
(1982).
7.
(1997).
9. Levitan, D., et al., Proc. Natl. Acad. Sci. USA, 93,
14940-14944 (1996).
10. Baumeister, R., et al., Genes Function, 1, 149-159
(1997).
11. Wong, P., et al., Nature, 387, 288-292 (1997)
U., Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I., et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S., et al., J. Neuroimmunol., 72, 155
(1997).
6. Birkedal-Hansen, H., et
V.M., and Saarialho-Kere, U., Exp.
Dermatol., 6(5), 199-213 (1997).
5. Halpert, I. et al., Proc. Natl. Acad. Sci. USA, 93(18),
9748-9753 (1996).
6. Chandler, S. et al., J. Neuroimmunol., 72(2)
(1997).
9. Levitan, D., et al., Proc. Natl. Acad. Sci. USA, 93,
14940-14944 (1996).
10. Baumeister, R., et al., Genes Function, 1, 149-159
(1997).
11. Wong, P., et al., Nature, 387, 288-292 (1997)
Characterization of
lymphotoxin-alpha-beta complexes on the surface
of mouse lymphocytes. J. Immunol., 159,
3288-3298 (1997).
3. Ettinger, R. et al., Disrupted splenic architecture,
but normal lymph node
Characterization of
lymphotoxin-alpha-beta complexes on the surface
of mouse lymphocytes. J. Immunol., 159, 3288-
3298 (1997).
3. Ettinger, R., et. al., Disrupted splenic architecture,
but normal lymph
U., Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I., et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S., et al., J. Neuroimmunol., 72, 155
(1997).
6. Birkedal-Hansen, H., et